2011;11:331. S8.1.2-36. Brett T, Arnold-Reed D, Phan C, et al. The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute car- diovascular risk reduction. Br J Gen Pract. 2012;62:e22 8. S8.1.2-37. Sekaran NK, Sussman JB, Xu A, et al. Providing clinicians with a patient's 10-year cardiovascular risk improves their statin prescrib- ing: a true experiment using clinical vignettes. BMC Cardiovasc Disord. 2013;13:90. S8.1.2-38. Sheridan SL, Draeger LB, Pignone MP, et al. The effect of a deci- sion aid intervention on decision making about coronary heart dis- ease risk reduction: secondary analyses of a randomized trial. BMC Med Inform Decis Mak. 2014;14:14. S8.1.2-39. Jansen J, Bonner C, McKinn S, et al. General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study. BMJ Open. 2014;4:e004812. S8.1.2-40. Vagholkar S, Zwar N, Jayasinghe UW, et al. Influence of cardiovas- cular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. Am Heart J. 2014;167:28 35. S8.1.2-41. Rafter N, Connor J, Hall J, et al. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. N Z Med J. 2005;118:U1676. S8.1.2-42. Yong TY, Phillipov G, Phillips PJ. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease. Med J Aust. 2007;186:622 4. S8.1.2-43. Webster RJ, Heeley EL, Peiris DP, et al. Gaps in cardiovascular dis- ease risk management in Australian general practice. Med J Aust. 2009;191:324 9. S8.1.2-44. Frikke-Schmidt R, Tybj rg-Hansen A, Schnohr P, et al. Common clinical practice versus new PRIM score in predicting coronary heart disease risk. Atherosclerosis. 2010;213:532 8. S8.1.2-45. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk percep- tion and evidence practice gaps in Australian general practice (the AusHEART study). Med J Aust. 2010;192:254 9. S8.1.2-46. 